1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - General
Scilex Holding Company

Scilex Holding Company

SCLX
Scilex Holding CompanyUS flagNASDAQ Capital Market
2.57
USD
-0.26
- -
18.08MMarket Cap

Total Valuation

Scilex Holding Company carries a market capitalization of 18.08M, placing it among publicly traded companies globally. Its enterprise value stands at 149.91M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap18.08M
Enterprise Value149.91M

Share Statistics

Scilex Holding Company currently has 7.03M shares outstanding.

Shares Outstanding7.03M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 2.09, and the price-to-book ratio stands at -0.18.

PE RatioN/A
PS Ratio2.09
PB Ratio-0.18
P/TBV Ratio-0.13
P/FCF Ratio-4.00
P/OCF Ratio-3.86

Enterprise Valuation

EV / Sales4.74
EV / EBITDAN/A
EV / EBITN/A
EV / FCF5.10

Financial Position

Scilex Holding Company maintains a current ratio of 0.07, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -31.49, indicating conservative leverage, while an interest coverage ratio of -22.36 demonstrates limited ability to service its debt obligations.

Current Ratio0.07
Quick Ratio0.05
Debt / Equity-31.49
Debt / EBITDA-0.35
Interest Coverage-22.36

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-265.10
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover4.21

Taxes

Income Tax14,000.00
Effective Tax RateN/A

Stock Price Statistics

Scilex Holding Company's stock has declined approximately -81.76011% over the past 52 weeks. The 50-day moving average sits at 4.92, while the 200-day moving average is 5.57.

Beta (5Y)N/A
52-Week Price Change-81.76011%
50-Day Moving Average4.92
200-Day Moving Average5.57
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Scilex Holding Company generated 31.61M in revenue and converted that into -447.12M in net income, yielding earnings per share of -54.90. EBITDA reached -277.27M, while operating income came in at -285.59M.

Revenue31.61M
Gross Profit17.54M
Operating Income-285.59M
Pretax Income-464.55M
Net Income-447.12M
EBITDA-277.27M
EBIT-285.59M
Earnings Per Share (EPS)-54.90

Balance Sheet

Scilex Holding Company holds 581,000.00 in cash and equivalents against 97.79M in total debt, resulting in a net debt position of 82.47M. Total book value stands at -308.32M, with working capital of -476.01M providing operational flexibility.

Cash & Cash Equivalents581,000.00
Total Debt97.79M
Net Debt82.47M
Equity (Book Value)-308.32M
Book Value Per Share-43.83
Working Capital-476.01M

Cash Flow

Scilex Holding Company produced -17.08M in operating cash flow over the past twelve months. After subtracting -600,000.00 in capital expenditures, free cash flow totaled -17.68M - equivalent to -2.09 per share.

Operating Cash Flow-17.08M
Capital Expenditures-600,000.00
Free Cash Flow-17.68M
FCF Per Share-2.09

Margins

Scilex Holding Company operates with a gross margin of 55.50, reflecting its pricing power and cost economics. The operating margin of -903.52 and net profit margin of -1,414.57 provide insight into operational efficiency.

Gross Margin55.50
Operating Margin-903.52
Pretax Margin-1,469.71
Profit Margin-1,414.57
EBITDA Margin-877.21

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-19.83
FCF Yield-24.97

Stock Splits

Scilex Holding Company's most recent stock split took place on April 15, 2025 with a 35:1 split ratio.

Last Split Date4/15/2025
Split Ratio35:1

Scores

Scilex Holding Company posts an Altman Z-Score of -23.63, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-23.63